NCT05639829

Brief Summary

Breast cancer survivors aged 60+ and with overweight/obesity who had completed chemotherapy 1-6 years earlier completed 8 weeks of 12-8 pm weekday-only time-restricted eating. The intervention was delivered by a registered dietitian call, twice-daily automated text messages asking about eating start/stop times, and three support phone calls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

November 9, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 6, 2022

Completed
Last Updated

April 12, 2023

Status Verified

November 1, 2022

Enrollment Period

12 months

First QC Date

November 9, 2022

Last Update Submit

April 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Framingham 10-year cardiovascular risk score (%)

    Calculated using the Canadian Cardiovascular scoring system

    8 weeks

Secondary Outcomes (15)

  • Visceral adipose tissue

    8 weeks

  • Thigh adipose tissue fraction

    8 weeks

  • Liver adipose tissue fraction

    8 weeks

  • Cardiorespiratory fitness

    8 weeks

  • Resting energy expenditure

    8 weeks

  • +10 more secondary outcomes

Other Outcomes (9)

  • Dietary intake

    8 weeks

  • Activity

    Change between measurement at baseline and 8 weeks

  • Adherence to intervention

    Ongoing for duration of intervention

  • +6 more other outcomes

Study Arms (1)

Weekday time-restricted eating

EXPERIMENTAL

The intervention consisted of 8 weeks of ad libitum TRE with a 12-8 pm 8-hour eating window on weekdays. Participants received instructions to only consume water, black coffee, or black tea from 8 pm to 12 pm on weekdays and during the weekend, where there were no restrictions on eating timing. No other dietary or physical activity instructions were given.

Behavioral: Time-restricted eating

Interventions

Restriction of calorie intake to an 8-hour window, with water only fasting in the remaining 16 hours of the 24-hour period

Also known as: intermittent fasting
Weekday time-restricted eating

Eligibility Criteria

Age60 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • history of early-stage (I-III) breast cancer
  • completed anthracycline-based chemotherapy 1-6 years earlier
  • aged ≥60 years
  • had a body mass index (BMI) \>25 kg/m2

You may not qualify if:

  • taking lipid, glucose, or weight-lowering medications
  • contraindications to maximal exercise testing or research MRI
  • unstable thyroid disorder
  • self-reported history of an eating disorder
  • self-reported diagnosis of type 1 or 2 diabetes
  • weight loss of ≥15 lbs in previous 3 months
  • working night shifts
  • could not provide consent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edmonton Clinic Health Academy

Edmonton, Alberta, Canada

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2022

First Posted

December 6, 2022

Study Start

August 5, 2020

Primary Completion

July 28, 2021

Study Completion

July 28, 2021

Last Updated

April 12, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations